Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Laryngeal Neoplasms × Fluorescein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 5 Melanoma 3 Stomach Neoplasms 2 Neoplasms 2 Glioma 2 Glioblastoma 2 Breast Neoplasms 2 Thyroid Diseases 1 Skin Neoplasms 1 Sarcoma 1 Pancreatic Neoplasms 1 Paget Disease, Extramammary 1 Ovarian Neoplasms 1 Neuroma, Acoustic 1 Laryngeal Neoplasms 1 Irritable Bowel Syndrome 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Diseases 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1 Cerebrovascular Disorders 1 Carcinoma, Hepatocellular 1 Astrocytoma 1 Adenomatous Polyps 1 Adenolymphoma 1

Interventions

Cisplatin 28 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Cetuximab 16 Specimen Handling 14 pembrolizumab 12 Carboplatin 11 Radiotherapy, Intensity-Modulated 10 Fluorouracil 10 Docetaxel 9 Surgical Procedures, Operative 8 Platinum 8 1,2-diaminocyclohexaneplatinum II citrate 8 Radiation 7 Paclitaxel 7 Biopsy 7 Drug Therapy 5 toripalimab 4 Taxes 4 Standard of Care 4 (225)Ac-DOTA-c(RGDyK) 4 X-Rays 3 Nutritional Status 3 Laser Therapy 3 Immunohistochemistry 3 Fluorodeoxyglucose F18 3 Chemoradiotherapy 3 Celecoxib 3 130-nm albumin-bound paclitaxel 3 motexafin gadolinium 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02628496 2016-09-09

Confocal Laser Microlaryngoscopy (CLMx)

Washington University School of Medicine

Phase NA Withdrawn

Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡